The GLP-1-producing preproglucagon (PPG) neurons located in the nucleus tractus solitarius (NTS) and the intermediate reticular nucleus of the medulla oblongata are the major source of endogenous GLP-1 in the central nervous system, which project widely throughout the central nervous system especially the autonomic control areas (Merchenthaler et al., 1999
PMID 3528148
Back Labhart, A (1978) 'Intuition, luck and misfortune in diabetes research', Diabetologia , 14, 353-58
Potential Outcomes of GLP-1 Treatment People who combine GLP-1 treatment with lifestyle changes often experience life-changing results
However, Oyikey does not appear to be registered in official MHRA, BP or US FDA databases
Because it targets GLP-1, GIP, and glucagon pathways, side effects and monitoring needs may be more complex than single-pathway medications